Neumora Therapeutics Rings the Opening Bell

About This Event

Neumora Therapeutics, Inc. (Nasdaq: NMRA), visits the Nasdaq MarketSite in Times Square. Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

In honor of the occasion, Paul L. Berns, Executive Chair and Co-Founder, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore